Y-mAbs Therapeutics, Inc.
Y-mAbs is a biopharmaceutical company focused on developing and commercializing antibody-based therapeutic products to treat cancers. In 2020, Y-mAbs received U.S. Food and Drug Administration (FDA) approval for a treatment option for a certain type of neuroblastoma.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No